Photo of Seth Epstein

Seth Epstein

  • ASSISTANT PROFESSOR Ophthalmology
Print ProfilePrint Profile

Education

  • B.A., Brandeis University
    Chemistry

  • M.D., Autonomous University of Guadalajara School of Medicine

  • Michigan Cancer Foundation
    Biochemistry & Chemistry

  • New York University Medical Center
    Immuno-Pathology and Immuno-Dermatology

  • Mount Sinai School of Medicine
    Infectious Disease of the Eye

  • Center for Advanced Training in Cell and Molecular Biology
    Cell Culture, Immunocytochemistry and Molecular Biology

Awards

  • -
    Marquis Who's Who in Science and Medicine

  • -
    Marquis Who's Who in America

  • -
    Outstanding Scientists of the 21st Century

  • -
    Eye Bank Association of America Association for Research in Vision and Ophthalmology, fellowship grant

  • -
    Dermatology Foundation, research grant

Research

cornea, Langerhans cells, ocular herpes simplex, laser keratectomy, keratitis, herpetic eye disease

Publications

Epstein S, Jan MS, Skittone LS, Small T, Asbell PA. Evaluation of cytokine-mediated chemotaxis of Ia+ Langerhans cells (LC) into the central cornea of mice: Effect of cyclosporine A (CsA), transforming growth factor (TGF)-b and interferons (IFNs)-a, b and g. Adv Ocular Immunol 1994; 1068: 7-10.

Asbell PA, Epstein S, Wallace JW, Epstein D, Stewart CC, Burger RM. Efficacy of cobalt chelates CTC-23, CTC-67, CTC-82 and CTC-96 for treatment of ocular herpes simplex infection in a rabbit model. Cornea 1997; 17(5): 550-557.

Epstein S, Fisher EM, Sternberg GJ, Franklin W, Gordon R, Ho JJ, Asbell PA. Recurrent Ocular Herpes Simplex Keratitis Following Excimer Laser Photorefractive Keratectomy in Rabbit Model. CLAO J 2001; 27(2): 94-99.

Epstein S, Nurozler M, Smetana CR, Asbell PA. Efficacy of Polyclonal Antibodies for Treatment of Ocular Herpes Simples Infection. Cornea 2001; 20(5): 495-500.

Herpetic Disease Study Group . Predictors of Recurrent Herpes Simplex Virus Keratitis. Cornea 2001; 20(2): 123-128.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Epstein during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.

  • Rapid Pathogen Screening (RPS), Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Basic Sciences Building Floor Annenberg 22 Room 18
10 East 101st Street
New York, NY 10029